CD4 and non-small cell lung carcinoma: Taking into account the CD4+/CD8+ ratio, it has been shown that a high CD8+/CD4+ baseline ratio in peripheral blood statistically significantly correlates with better prognosis in early-stage NSCLC (HR 0.19) [71].